TESTOGEL

This brand name is authorized in Australia, Austria, Cyprus, Estonia, Finland, Hong Kong SAR China, Ireland, Malta, Spain, Turkey, UK.

Active ingredients

The drug TESTOGEL contains one active pharmaceutical ingredient (API):

1	Testosterone UNII 3XMK78S47O - TESTOSTERONE
	Testosterone, secreted by the testes and its major metabolite dihydrotestosterone (DHT), is responsible for the development of the external and internal genital organs and for maintaining the secondary sexual characteristics (stimulating hair growth, deepening of the voice, development of the libido); for a general effect on protein anabolism; for development of skeletal muscle and body fat distribution; for a reduction in urinary nitrogen, sodium, potassium, chloride, phosphate and water excretion.
	Read more about Testosterone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TESTOGEL Gel	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03BA03	Testosterone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03B Androgens → G03BA 3-oxoandrosten (4) derivatives
Discover more medicines within G03BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10380H, 8830R
EE	Ravimiamet	1375590
ES	Centro de información online de medicamentos de la AEMPS	65016, 80617
FI	Lääkealan turvallisuus- ja kehittämiskeskus	011738
GB	Medicines & Healthcare Products Regulatory Agency	146631, 350204, 46080
HK	Department of Health Drug Office	65500
IE	Health Products Regulatory Authority	49129, 62305
MT	Medicines Authority	MA727/00301
TR	İlaç ve Tıbbi Cihaz Kurumu	8699538347316